Correlation Between Inozyme Pharma and Monte Rosa
Can any of the company-specific risk be diversified away by investing in both Inozyme Pharma and Monte Rosa at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Inozyme Pharma and Monte Rosa into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Inozyme Pharma and Monte Rosa Therapeutics, you can compare the effects of market volatilities on Inozyme Pharma and Monte Rosa and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Inozyme Pharma with a short position of Monte Rosa. Check out your portfolio center. Please also check ongoing floating volatility patterns of Inozyme Pharma and Monte Rosa.
Diversification Opportunities for Inozyme Pharma and Monte Rosa
-0.67 | Correlation Coefficient |
Excellent diversification
The 3 months correlation between Inozyme and Monte is -0.67. Overlapping area represents the amount of risk that can be diversified away by holding Inozyme Pharma and Monte Rosa Therapeutics in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Monte Rosa Therapeutics and Inozyme Pharma is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Inozyme Pharma are associated (or correlated) with Monte Rosa. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Monte Rosa Therapeutics has no effect on the direction of Inozyme Pharma i.e., Inozyme Pharma and Monte Rosa go up and down completely randomly.
Pair Corralation between Inozyme Pharma and Monte Rosa
Given the investment horizon of 90 days Inozyme Pharma is expected to under-perform the Monte Rosa. But the stock apears to be less risky and, when comparing its historical volatility, Inozyme Pharma is 5.67 times less risky than Monte Rosa. The stock trades about -0.64 of its potential returns per unit of risk. The Monte Rosa Therapeutics is currently generating about 0.19 of returns per unit of risk over similar time horizon. If you would invest 489.00 in Monte Rosa Therapeutics on August 26, 2024 and sell it today you would earn a total of 360.00 from holding Monte Rosa Therapeutics or generate 73.62% return on investment over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Against |
| Strength | Weak |
| Accuracy | 100.0% |
| Values | Daily Returns |
Inozyme Pharma vs. Monte Rosa Therapeutics
Performance |
| Timeline |
| Inozyme Pharma |
| Monte Rosa Therapeutics |
Inozyme Pharma and Monte Rosa Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with Inozyme Pharma and Monte Rosa
The main advantage of trading using opposite Inozyme Pharma and Monte Rosa positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Inozyme Pharma position performs unexpectedly, Monte Rosa can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Monte Rosa will offset losses from the drop in Monte Rosa's long position.| Inozyme Pharma vs. Day One Biopharmaceuticals | Inozyme Pharma vs. X4 Pharmaceuticals | Inozyme Pharma vs. Acumen Pharmaceuticals | Inozyme Pharma vs. Mereo BioPharma Group |
| Monte Rosa vs. Eliem Therapeutics | Monte Rosa vs. HCW Biologics | Monte Rosa vs. Scpharmaceuticals | Monte Rosa vs. Milestone Pharmaceuticals |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the ETFs module to find actively traded Exchange Traded Funds (ETF) from around the world.
Other Complementary Tools
| Risk-Return Analysis View associations between returns expected from investment and the risk you assume | |
| Pair Correlation Compare performance and examine fundamental relationship between any two equity instruments | |
| Volatility Analysis Get historical volatility and risk analysis based on latest market data | |
| Commodity Channel Use Commodity Channel Index to analyze current equity momentum | |
| Premium Stories Follow Macroaxis premium stories from verified contributors across different equity types, categories and coverage scope |